Double your impact this holiday season
Follow-up after treatment for lung cancer
Follow-up after treatment is an important part of cancer care. Follow-up for lung cancer is often shared among the cancer specialists (oncologist, surgeon and radiation therapist) and your family doctor. Your healthcare team will work with you to decide on follow-up care to meet your needs.
Don’t wait until your next scheduled appointment to report any new symptoms and symptoms that don’t go away. Tell your healthcare team if you:
- have a cough that is getting worse
- have shortness of breath or difficulty breathing
- are coughing up blood
- have headaches
- have pain in your chest, stomach, back, legs or hips
The chance that lung cancer will come back (recur) is greatest within 2 years, so close follow-up is needed during this time.
Schedule for follow-up visits
Follow-up visits for lung cancer may be scheduled:
- 3 to 6 months after initial treatment
- every 6 months for 2 years
During follow-up visits
During a follow-up visit, your healthcare team will usually ask questions about the side effects of treatment and how you’re coping. If you were a smoker when you were diagnosed, they will also ask if you have stopped smoking and offer you help to quit if you still smoke.
Your doctor may do a physical exam, including:
- listening to the lungs or the remaining lung
- feeling the abdomen for any swelling or lumps
Tests are often part of follow-up care. You may have:
- a CT scan to see if cancer has come back in the chest
- a chest x-ray if a CT scan is not used
- blood chemistry tests to check if cancer has spread to the liver or bones
If the cancer has come back, you and your healthcare team will discuss a plan for your treatment and care.
Questions to ask about follow-up
To make the decisions that are right for you, ask your healthcare team questions about follow-up.
Now I know that I will help someone with cancer even after I’m gone. It’s a footprint I want to leave behind me.
Together we can reduce the burden of cancer
Last year, we only had the resources available to fund 40% of high-priority research projects. Imagine the impact we could have if we were able to fund 100%.